AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$23.94 USD
+0.29 (1.23%)
Updated May 31, 2024 04:00 PM ET
After-Market: $23.95 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
AnaptysBio, Inc. [ANAB]
Reports for Purchase
Showing records 21 - 40 ( 156 total )
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Ditching Alopecia Areata for Rheumatoid Arthritis and More in 2023
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Redeploying Pipeline to Develop Anti-Checkpoint Receptor Therapeutics; Assuming Coverage With Buy Rating and $35 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
The Wedbush Monthly Check-Up: April 2022
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Strategic Review Under New Leadership; Pipeline Assumptions Steady for Now
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department